GuideNephrology

Chronic kidney disease in adults: British Columbia guideline (BC Guidelines)

Summary of the BC guideline for identifying, evaluating and managing adult CKD in primary care, with nephrology referral criteria.

Updated 3 November 2026

When to use it

Primary care and internal medicine: whom to screen, how to confirm and stage CKD, which treatment targets to set and when to refer.

Warning

Guideline from 2019 (page reviewed in 2026). Recommendations on SGLT2i and finerenone in CKD without diabetes are broader in KDIGO 2024; check against the current local guideline.

Screening and diagnosis

• Screen every 1–2 years (yearly in diabetes) with eGFR, urine dipstick and ACR people with diabetes, hypertension, cardiovascular disease, family history of kidney disease, high-risk ethnicity or previous acute kidney injury. Age alone is not an indication.

• CKD: eGFR < 60 ml/min/1.73 m² for ≥ 3 months, or markers of kidney damage (albuminuria, sediment or structural abnormalities) even with eGFR ≥ 60.

• ACR categories: < 3.0 mg/mmol (normal to mildly increased), 3.0–30 (moderately increased), > 30 (severely increased).

• Stage by cause, eGFR and albuminuria (CGA).

Keep reading in the app

  • Treatment targets
  • Monitoring
  • Nephrology referral

Practical tip

A single abnormal value is not CKD: the abnormality must be confirmed over more than 3 months.

2 more practical tips in the app.

Reference

Official source: BC Guidelines: Chronic Kidney Disease (Government of British Columbia)

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top